Cover Image
市場調查報告書

筆針頭的全球市場 至2021年的分析與預測:各類型、針長、用途 (胰島素,GLP-1,生長激素)、購買形態

Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 318506
出版日期 內容資訊 英文 186 Pages
訂單完成後即時交付
價格
Back to Top
筆針頭的全球市場 至2021年的分析與預測:各類型、針長、用途 (胰島素,GLP-1,生長激素)、購買形態 Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021
出版日期: 2016年06月24日 內容資訊: 英文 186 Pages
簡介

全球筆針頭的市場規模,預計從2016年的16億5000萬美元,到2021年的28億1000萬美元,以11.2%的年複合成長率 (CAGR) 擴大。安全型筆針頭的普及和醫療費償付制度的改善,政府的輔助活動,注射器及瓶子的優勢等,成為市場成長的大要素。

本報告以全球筆針頭市場為焦點,提供市場概要,市場發展促進、阻礙因素,市場上課題及機會,各類型、各針長、各用途、各購買形態、各地區的市場現況與展望相關調查分析,競爭環境,主要企業簡介彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 高級見解

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 市場發展推動因素
      • 在部分國家良好的醫療費償付環境與政府的輔助
      • 胰島素筆針對注射器及瓶子的優勢
      • 技術進步
      • 糖尿病患者數的增加
      • 提升筆針頭知名度的會議、活動
    • 市場發展阻礙因素
      • 開發中國家中惡劣的補償結構
      • 對針的不安感
      • 替代性的藥物輸送手段 (口服藥、吸入藥、奈米技術式經皮/吸引藥)
      • 美國的內分泌科醫生的不足
      • 筆針頭的再利用
      • 開發中國家中惡劣的補償結構
      • 對針的不安
      • 美國的內分泌學者不足
    • 市場機會
      • 安全針
      • GLP-1類比
    • 課題
      • 標準型筆針頭再利用回數的抑制
      • 從傳統的注射器改成最新型設備的抵抗感

第6章 產業分析

  • 簡介
  • 波特的五力分析
  • 競爭的強度
    • 評估參數
    • 評分安上方法
    • 競爭強度評分,各企業
      • BD的競爭強度評分
      • Novo Nordisk的競爭強度評分
      • Ypsomed的競爭強度評分
    • BD,Novo Nordisk及Ypsomed的競爭強度
    • 評估參數比較,各企業
      • 價格設定
      • 產品系列
      • 產品銷售/技術進步
      • 生產能力 (2015年)
      • 地區的存在感
      • 促銷、行銷活動
      • 贊助商/捐獻/教育/認知度提高宣傳活動
      • M&A、夥伴關係、聯盟、協定、產業擴張
      • 經驗年數
      • 授權/認證評估/獲獎經歷

第7章 筆針頭市場:各類型

  • 簡介
  • 標準型筆針頭
  • 安全型筆針頭

第8章 筆針頭市場:各針長

  • 簡介
  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm

第9章 筆針頭市場:各用途

  • 簡介
  • 胰島素
  • GLP-1 (Glucagon-Like Peptide-1)
  • 生長激素

第10章 筆針頭市場:各購買形態

  • 簡介
  • 零售業者
  • 零售業者之外

第11章 筆針頭市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞洲
    • 日本
    • 中國
    • 印度
    • 其他亞洲國家
  • 其他地區 (RoW)
    • 南美
    • 太平洋各國
    • 中東、非洲

第12章 筆針頭的經銷商

第13章 競爭情形

  • 概要
  • 市場佔有率分析
    • 簡介
    • Becton, Dickinson And Co.
    • Novo Nordisk A/S
    • Ypsomed Holding AG
    • 其他
  • 競爭情形、趨勢
    • 行銷、推銷
    • 產業擴張
    • 新產品銷售
    • 其他

第14章 企業簡介

  • 簡介
  • Becton, Dickinson And Company
  • Novo Nordisk A/S
  • Ypsomed Holding Ag
  • Owen Mumford, Ltd.
  • Htl-Strefa S.A.
  • B. Braun Melsungen
  • Terumo Corporation
  • Ultimed, Inc. (LDI, LTD.)
  • Allison Medical, Inc.
  • Artsana S.P.A.

第15章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 2851

The pen needles market is projected to reach USD 2.81 billion by 2021 from USD 1.65 billion in 2016, growing at a CAGR of 11.2% during the forecast period of 2016 to 2021.

Over the years, the pen needles market has witnessed various technological advancements in order to cater to the growing demand for safety injections in the healthcare industry. These advancements have led to the development of safety pen needles with an aim to reduce pain, increase comfort, and most importantly reduce needlestick injuries (NSIs). Other factors contributing to the growth of the pen needles market include favorable reimbursement environment and government support in selected countries, advantages of insulin pens over syringes and vials, and growing diabetic population.

The standard pen needles segment is expected to account for the largest share of the pen needles market, by type, in 2016. Increasing diabetic population, rising awareness about the use of pen needles for insulin administration, favorable reimbursement scenario in selected countries, and low costs as compared to safety pen needles are major factors driving the market for standard pen needles. The 8mm pen needles segment is expected to account for the largest share of the pen needles market, by needle length, in 2016. These pen needles are the most prescribed/preferred as they can be conveniently used on normal as well as obese adult patients. The insulin therapy segment is expected to dominate the pen needles market, by therapy, in 2016. Growth in the insulin therapy segment can be attributed to the increasing use of insulin by the diabetic population and increasing awareness about insulin self-administration among type 1 and type 2 diabetes patients. The retail mode of purchase segment is expected to dominate the pen needles market, by mode of purchase, in 2016. The large share of this segment can mainly be attributed to the increasing purchase of pen needles directly by customers at pharmacies, retail stores, mail orders, and online through websites. Retail stores offer significant discounts on online/retail purchases and provide convenience to customers.

Europe is expected to account for the largest share in the pen needles market in 2016, followed by North America, Asia, and the Rest of the World (RoW). The large share of the European region can be attributed to EU's Directive on the prevention of sharp injuries in hospitals and the healthcare sector; regulatory frameworks to minimize needlestick injuries & boost the use of safety-engineered devices; high diabetes prevalence and favorable reimbursement for pen needles in Germany; activities to pool funds for diabetes care & research in the U.K.; high insurance coverage and increase in aging population and affordability in France; awareness campaigns for diabetes in Italy; large pool of diabetic population and regulations mandating the use of safety pen needles in Spain; and high diabetes prevalence in Russia, Poland, Romania, and Ukraine. Asia is expected to witness the highest growth rate in the forecast period, mainly due to the rapidly growing diabetic population, increasing awareness, and rising adoption of pen devices for insulin delivery.

The global pen needles market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market.

Prominent players in the pen needles market include Becton, Dickinson, and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holdings AG (Switzerland), Owen Mumford, Ltd. (U.K.), HTL-STREFA S.A. (Poland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), and Artsana S.p.a. (Italy).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the pen needle market. The report analyzes the market based on type, needle length, therapy, and mode of purchase
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pen needle market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various pen needles across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the pen needles market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the pen needles market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. PEN NEEDLES MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: PEN NEEDLES MARKET, BY LENGTH
  • 4.3. PEN NEEDLES MARKET, BY TYPE
  • 4.4. PEN NEEDLES MARKET, BY LENGTH
  • 4.5. PEN NEEDLES MARKET, BY MODE OF PURCHASE
  • 4.6. GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Favorable reimbursement environment and government support in selected countries
      • 5.3.1.2. Advantages of insulin pens over syringes and vials
      • 5.3.1.3. Technological advancements
      • 5.3.1.4. Growing diabetic population
      • 5.3.1.5. Conferences, Meetings, and Congresses to create pen needle awareness
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Poor reimbursement structure in developing countries
      • 5.3.2.2. Needle anxiety
      • 5.3.2.3. Alternative drug delivery methods
        • 5.3.2.3.1. Oral diabetic agents and oral insulin
        • 5.3.2.3.2. Inhalable Insulin
        • 5.3.2.3.3. Nanotechnology to aid in transdermal and inhalational route of administering proteins and peptides
      • 5.3.2.4. Severe shortage of endocrinologists in the U.S.
      • 5.3.2.5. Reuse of pen needles
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Safety needles
      • 5.3.3.2. GLP-1. analogues
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Minimizing the reuse of standard pen needles
      • 5.3.4.2. Resistance against switching from conventional devices to advanced devices

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. PORTER'S FIVE FORCES ANALYSIS
    • 6.2.1. THREAT OF NEW ENTRANTS
    • 6.2.2. BARGAINING POWER OF SUPPLIERS
    • 6.2.3. BARGAINING POWER OF BUYERS
    • 6.2.4. SEGMENT RIVALRY
    • 6.2.5. THREAT OF SUBSTITUTES
  • 6.3. COMPETITIVE INTENSITY
    • 6.3.1. EVALUATION PARAMETERS
    • 6.3.2. SCORING METHODOLOGY
    • 6.3.3. COMPETITIVE INTENSITY SCORE, BY COMPANY
      • 6.3.3.1. Competitive intensity score for BD
      • 6.3.3.2. Competitive intensity score for Novo Nordisk
      • 6.3.3.3. Competitive intensity score for Ypsomed
    • 6.3.4. COMPETITIVE INTENSITY MAPPING OF BD, NOVO NORDISK, AND YPSOMED
    • 6.3.5. COMPARISON OF EVALUATION PARAMETERS, BY COMPANY
      • 6.3.5.1. Pricing
      • 6.3.5.2. Product portfolio
      • 6.3.5.3. Product launches/Technological advancements
      • 6.3.5.4. Production capacity (2015)
      • 6.3.5.5. Geographical presence
      • 6.3.5.6. Promotional/Marketing activities
      • 6.3.5.7. Sponsorships/Donations/Education/Awareness campaigns
      • 6.3.5.8. M&As, Partnerships, Collaborations, Agreements, and Expansions
      • 6.3.5.9. Years of experience
      • 6.3.5.10. Certifications/Accreditations/Awards

7. PEN NEEDLES MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. STANDARD PEN NEEDLES
  • 7.3. SAFETY PEN NEEDLES

8. PEN NEEDLES MARKET, BY NEEDLE LENGTH

  • 8.1. INTRODUCTION
  • 8.2. 4MM
  • 8.3. 5MM
  • 8.4. 6. MM
  • 8.5. 8MM
  • 8.6. 10MM
  • 8.7. 12MM

9. PEN NEEDLES MARKET, BY THERAPY

  • 9.1. INTRODUCTION
  • 9.2. INSULIN
  • 9.3. GLP-1
  • 9.4. GROWTH HORMONES

10. PEN NEEDLES MARKET, BY MODE OF PURCHASE

  • 10.1. INTRODUCTION
  • 10.2. RETAIL
  • 10.3. NON-RETAIL

11. PEN NEEDLES MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
      • 11.2.1.1. Growing diabetes prevalence and favorable reimbursement scenario for pen needles
      • 11.2.1.2. Federal initiatives to stimulate the U.S. pen needles market
      • 11.2.1.3. Focus of leading players on increasing market penetration in the U.S.
      • 11.2.1.4. Improvements in pen needle technologies to eliminate needlestick injuries
      • 11.2.1.5. Low penetration of pen injectors in the U.S. as compared to Europe
    • 11.2.2. CANADA
      • 11.2.2.1. High diabetes prevalence
      • 11.2.2.2. Regulations for the use of safety-engineered needles
      • 11.2.2.3. Government support for pen needles in Alberta
  • 11.3. EUROPE
    • 11.3.1. GERMANY
      • 11.3.1.1. Regulatory framework to minimize needlestick injuries & boost use of safety-engineered devices
      • 11.3.1.2. High diabetes prevalence and reimbursement for pen needles
    • 11.3.2. U.K.
      • 11.3.2.1. Activities to pool funds for diabetes care & research
    • 11.3.3. FRANCE
      • 11.3.3.1. Conferences and exhibitions to increase exposure for pen needles players in French market
      • 11.3.3.2. Higher insurance coverage and increase in aging population and affordability
    • 11.3.4. ITALY
      • 11.3.4.1. Wide regional variations in terms of benefits and coverage to slow growth in Italy
      • 11.3.4.2. Awareness campaigns for diabetes in Italy to propel the market growth
    • 11.3.5. SPAIN
      • 11.3.5.1. Large pool of diabetic population, regulations mandating the use of safety pen needles
    • 11.3.6. REST OF EUROPE
      • 11.3.6.1. High diabetes prevalence in Russia, Poland, Romania, and Ukraine
  • 11.4. ASIA
    • 11.4.1. JAPAN
      • 11.4.1.1. High adoption of insulin pens and approval of injectable insulin
    • 11.4.2. CHINA
      • 11.4.2.1. Growing presence of global and local players in China
      • 11.4.2.2. High diabetes incidence and adoption of insulin pens
      • 11.4.2.3. High reuse rate & lack of reimbursement to limit market growth
    • 11.4.3. INDIA
      • 11.4.3.1. Growing presence of global players in India
      • 11.4.3.2. Low pen needle penetration, lack of awareness to restrain market growth
    • 11.4.4. REST OF ASIA
      • 11.4.4.1. Vietnam, a potential market for pen needles
      • 11.4.4.2. Increase in pen needles likely in Singapore & Malaysia
  • 11.5. REST OF THE WORLD (ROW)
    • 11.5.1. LATIN AMERICA
      • 11.5.1.1. Increasing diabetic population and rising awareness on diabetes in Brazil
    • 11.5.2. PACIFIC COUNTRIES
      • 11.5.2.1. Amendments in NDSS to increase access to diabetic products in Australia
      • 11.5.2.2. Favorable reimbursement scenario and presence of charity organizations in New Zealand
    • 11.5.3. MIDDLE EAST & AFRICA
      • 11.5.3.1. Presence of local & international pen needle manufacturers and rising awareness on pen needles to bolster the market
      • 11.5.3.2. Increasing diabetic population, rising awareness on diabetes

12. PEN NEEDLE DISTRIBUTOR LIST

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET SHARE ANALYSIS
    • 13.2.1. INTRODUCTION
    • 13.2.2. BECTON, DICKINSON & CO.
    • 13.2.3. NOVO NORDISK A/S
    • 13.2.4. YPSOMED HOLDING AG
    • 13.2.5. OTHERS
  • 13.3. COMPETITIVE SITUATION AND TRENDS
    • 13.3.1. MARKETING AND PROMOTION
    • 13.3.2. EXPANSION
    • 13.3.3. PRODUCT LAUNCH
    • 13.3.4. OTHERS

14. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 14.1. INTRODUCTION
  • 14.2. BECTON, DICKINSON AND COMPANY
  • 14.3. NOVO NORDISK A/S
  • 14.4. YPSOMED HOLDING AG
  • 14.5. OWEN MUMFORD, LTD.
  • 14.6. HTL-STREFA S.A.
  • 14.7. B. BRAUN MELSUNGEN
  • 14.8. TERUMO CORPORATION
  • 14.9. ULTIMED, INC. (LDI, LTD.)
  • 14.10. ALLISON MEDICAL, INC.
  • 14.11. ARTSANA S.P.A.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. DISCUSSION GUIDE
  • 15.2. COMPANY DEVELOPMENTS (2013-2016)
  • 15.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.5. AVAILABLE CUSTOMIZATIONS
  • 15.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: 10 COUNTRIES/TERRITORIES WITH THE HIGHEST NUMBER OF DIABETICS (20-79 YEARS), 2015 & 2040
  • TABLE 2: FAVORABLE REIMBURSEMENT ENVIRONMENT IN NORTH AMERICA & EUROPE AND GROWING DIABETIC POPULATION TO DRIVE THE GROWTH OF THE GLOBAL PEN NEEDLES MARKET
  • TABLE 3: POOR REIMBURSEMENT STRUCTURE IN DEVELOPING COUNTRIES IS RESTRAINING THE GROWTH OF THE PEN NEEDLES MARKET
  • TABLE 4: SAFETY NEEDLES TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES IN THE PEN NEEDLES MARKET
  • TABLE 5: MINIMIZING THE REUSE OF PEN NEEDLES IS A MAJOR MARKET CHALLENGE
  • TABLE 6: EVALUATION PARAMETERS AND SCORES
  • TABLE 7: COMPETITIVE INTENSITY FOR BD
  • TABLE 8: COMPETITIVE INTENSITY FOR NOVO NORDISK
  • TABLE 9: COMPETITIVE INTENSITY FOR YPSOMED
  • TABLE 10: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 12: STANDARD PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: STANDARD PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (MILLION UNITS)
  • TABLE 14: SAFETY PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: STANDARD PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (MILLION UNITS)
  • TABLE 16: PEN NEEDLES MARKET SIZE, BY LENGTH, 2016-2021 (USD MILLION)
  • TABLE 17: 4MM PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: 5MM PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: 6MM PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: 8MM PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: 10MM PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: 12MM PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: PEN NEEDLES MARKET SIZE, BY THERAPY, 2014-2021 (USD MILLION)
  • TABLE 24: INDICATIVE LIST OF INSULIN DEVELOPMENTS BY VARIOUS COMPANIES
  • TABLE 25: INSULIN MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: GLP-1 MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: GROWTH HORMONES MARKET SIZE, BY REGION, 2014-2021 USD MILLION)
  • TABLE 28: PEN NEEDLES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 29: PEN NEEDLES MARKET SIZE FOR RETAIL PURCHASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: INDICATIVE LIST OF REGULATORY ACTS
  • TABLE 31: PEN NEEDLES MARKET SIZE FOR NON-RETAIL PURCHASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (MILLION UNITS)
  • TABLE 34: NORTH AMERICA: PEN NEEDLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 37: NORTH AMERICA: PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: PEN NEEDLES MARKET SIZE, BY THERAPY, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: PEN NEEDLES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 40: ESTIMATED COST-SAVINGS FROM THE USE OF SAFETY- ENGINEERED DEVICES IN THE U.S.
  • TABLE 41: U.S.: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 42: U.S.: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 43: CANADA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 45: EUROPE: PEN NEEDLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: PEN NEEDLES MARKET SIZE, BY COUNTRY, 2014-2021 (MILLION UN ITS)
  • TABLE 47: EUROPE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 49: EUROPE: PEN NEEDLES MARKET SIZE, BY LENGTH, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: PEN NEEDLES MARKET SIZE, BY THERAPY, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: PEN NEEDLES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 52: ESTIMATED ANNUAL NUMBER OF NSI-CAUSED INFECTIONS IN GERMAN HOSPITALS
  • TABLE 53: GERMANY: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: GERMANY: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 55: INSTITUTIONS THAT RECEIVED FUNDING OF MORE THAN GBP 100,000 (USD 145,805)
  • TABLE 56: HIGHLIGHTS OF DIABETES U.K. ACTIVITIES, 2013
  • TABLE 57: U.K.: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: U.K.: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 59: FRANCE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: FRANCE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 61: HIGHLIGHTS OF AWARENESS CAMPAIGN CONDUCTED BY HAVAS PR & IDF IN ITALY
  • TABLE 62: ITALY: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: ITALY: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 64: SPAIN: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: SPAIN: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 66: EUROPEAN COUNTRIES WITH HIGHEST DIABETIC CASES AND DIABETES-RELATED DEATHS IN 2015
  • TABLE 67: ROE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: ROE: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 69: ASIA: PEN NEEDLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 70: ASIA: PEN NEEDLES MARKET SIZE, BY COUNTRY, 2014-2021 (MILLION UNITS)
  • TABLE 71: ASIA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: ASIA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 73: ASIA: PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2014-2021 (USD MILLION)
  • TABLE 74: ASIA: PEN NEEDLES MARKET SIZE, BY THERAPY, 2014-2021 (USD MILLION)
  • TABLE 75: ASIA: PEN NEEDLES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 76: JAPAN: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: JAPAN: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 78: INDICATIVE LIST OF PEN NEEDLE MANUFACTURERS IN CHINA
  • TABLE 79: CHINA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: CHINA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (MILLION UNITS)
  • TABLE 81: INDIA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: INDIA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 83: ROA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: ROA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 85: ROW: PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 86: ROW: PEN NEEDLES MARKET SIZE, BY REGION, 2014-2021 (MILLION UNITS)
  • TABLE 87: ROW: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: ROW: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 89: ROW: PEN NEEDLES MARKET SIZE, BY LENGTH, 2014-2021 (USD MILLION)
  • TABLE 90: ROW: PEN NEEDLES MARKET SIZE, BY THERAPY, 2014-2021 (USD MILLION)
  • TABLE 91: ROW: PEN NEEDLES MARKET SIZE, BY MODE OF PURCHASE, 2014-2021 (USD MILLION)
  • TABLE 92: LATIN AMERICA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: LATIN AMERICA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 94: PEN NEEDLES AVAILABLE IN NEW ZEALAND
  • TABLE 95: PACIFIC COUNTRIES: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: PACIFIC COUNTRIES: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 97: MIDDLE EAST & AFRICA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: MIDDLE EAST & AFRICA: PEN NEEDLES MARKET SIZE, BY TYPE, 2014-2021 (THOUSAND UNITS)
  • TABLE 99: MARKETING AND PROMOTION, 2014-2016
  • TABLE 100: EXPANSION, 2013-2015
  • TABLE 101: PRODUCT LAUNCH, 2013-2015
  • TABLE 102: OTHERS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL PEN NEEDLES MARKET SEGMENTATION
  • FIGURE 2: GLOBAL PEN NEEDLES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: STANDARD PEN NEEDLES MARKET TO CONTRIBUTE TO THE LARGER SHARE OF THE PEN NEEDLES MARKET IN 2016
  • FIGURE 8: 8MM PEN NEEDLES ARE ESTIMATED TO COMMAND THE LARGEST SHARE IN 2016
  • FIGURE 9: INSULIN THERAPY SEGMENT IS EXPECTED TO CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD (2016-2021)
  • FIGURE 10: ASIA IS SLATED TO WITNESS THE HIGHEST GROWTH IN THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD (2016-2021)
  • FIGURE 11: ASIAN PEN NEEDLES MARKET TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 12: EUROPE TO DOMINATE THE GLOBAL PEN NEEDLES MARKET
  • FIGURE 13: SAFETY PEN NEEDLES SEGMENT TO GROW AT THE HIGHEST RATE
  • FIGURE 14: 8MM PEN NEEDLES SEGMENT TO COMMAND THE HIGHEST MARKET SIZE IN 2016
  • FIGURE 15: RETAIL SEGMENT EXPECTED TO COMMAND THE LARGEST SIZE OF THE PEN NEEDLES MARKET IN 2021
  • FIGURE 16: ASIA TO REGISTER HIGHEST GROWTH RATE FROM 2016 TO 2021
  • FIGURE 17: PEN NEEDLES MARKET SEGMENTATION
  • FIGURE 18: PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 19: PORTER'S FIVE FORCES ANALYSIS: PEN NEEDLES MARKET
  • FIGURE 20: SCORING METHODOLOGY
  • FIGURE 21: COMPARISON OF COMPETITIVE INTENSITY SCORES: BD, NOVO NORDISK, AND YPSOMED
  • FIGURE 22: RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORES AND PEN NEEDLE FOCUS
  • FIGURE 23: SAFETY PEN NEEDLES BY BD AND STANDARD PEN NEEDLES BY NOVO NORDISK ARE PREMIUM-PRICED
  • FIGURE 24: BD HAS A ROBUST PORTFOLIO OF BOTH STANDARD AND SAFETY PEN NEEDLES
  • FIGURE 25: BD HAS MORE FOCUS ON INNOVATION IN ITS PEN NEEDLES BUSINESS
  • FIGURE 26: BD HAS THE HIGHEST PRODUCTION CAPACITY OF PEN NEEDLES
  • FIGURE 27: BD AND NOVO NORDISK HAVE A STRONG GEOGRAPHIC PRESENCE
  • FIGURE 28: BD AND NOVO NORDISK SHOWCASE HIGH FOCUS ON MARKETING AND PROMOTIONAL ACTIVITIES
  • FIGURE 29: NOVO NORDISK HAS HIGH FOCUS ON DIABETES EDUCATION AND AWARENESS
  • FIGURE 30: NOVO NORDISK AGGRESSIVELY FOLLOWS THE GROWTH STRATEGY OF PARTNERSHIPS AND AGREEMENTS
  • FIGURE 31: NOVO NORDISK IS THE MOST EXPERIENCED FIRM IN PEN NEEDLES MARKET
  • FIGURE 32: BD, NOVO NORDISK, AND YPSOMED EQUALLY EXHIBIT HIGH COMPLIANCE WITH INDUSTRY STANDARDS
  • FIGURE 33: INDICATIVE LIST OF KEY PLAYERS (MANUFACTURERS/MARKETERS) IN THE GLOBAL PEN NEEDLES MARKET
  • FIGURE 34: INDICATIVE LIST OF PLAYERS (MANUFACTURERS/MARKETERS) IN PEN NEEDLES MARKET IN SPECIFIC COUNTRIES
  • FIGURE 35: STANDARD PEN NEEDLES SEGMENT TO COMMAND THE LARGEST MARKET SIZE IN 2016
  • FIGURE 36: AVAILABILITY OF PEN NEEDLES, BY COMPANY
  • FIGURE 37: 8MM PEN NEEDLES SEGMENT TO COMMAND THE LARGEST MARKET SIZE IN 2016 AND 2021
  • FIGURE 38: INSULIN THERAPY SEGMENT TO COMMAND THE LARGEST SIZE OF PEN NEEDLES MARKET IN 2016
  • FIGURE 39: RETAIL PURCHASES SEGMENT TO COMMAND THE LARGEST MARKET SHARE IN 2016
  • FIGURE 40: EUROPE TO COMMAND THE LARGEST SHARE OF THE GLOBAL PEN NEEDLES MARKET IN 2016
  • FIGURE 41: U.S. TO WITNESS HIGHEST GROWTH IN THE NORTH AMERICAN PEN NEEDLES MARKET FROM 2016 TO 2020
  • FIGURE 42: EUROPEAN PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 43: DIABETES U.K.: FUNDS RAISED VS. FUNDS INVESTED
  • FIGURE 44: CHINA TO WITNESS HIGHEST GROWTH IN THE ASIAN PEN NEEDLES MARKET FROM 2016 TO 2021
  • FIGURE 45: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 46: GROWTH STRATEGIES, BY COMPANY
  • FIGURE 47: COMPANIES ADOPTED MARKETING & PROMOTION AS THE KEY GROWTH STRATEGY FROM 2013-2016
  • FIGURE 48: GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
  • FIGURE 49: BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT
  • FIGURE 50: NOVO NORDISK A/S: COMPANY SNAPSHOT
  • FIGURE 51: YPSOMED HOLDING AG: COMPANY SNAPSHOT
  • FIGURE 52: B. BRAUN MELSUNGEN: COMPANY SNAPSHOT
  • FIGURE 53: TERUMO CORPORATION: COMPANY SNAPSHOT
Back to Top